OAM
DPLO

Oppenheimer Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Oppenheimer Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,167
Closed -$69K – 1660
2018
Q4 		$69K Buy
+5,167
New +$87.1K ﹤0.01% 1280
2018
Q1 		– Sell
-29,079
Closed -$602K – 1203
2017
Q4 		$602K Hold
29,079
– – 0.02% 740
2017
Q3 		$602K Buy
29,079
+2,049
+8% +$34.6K 0.02% 744
2017
Q2 		$400K Sell
27,030
-506
-2% -$8.43K 0.01% 846
2017
Q1 		$439K Buy
+27,536
New +$397K 0.01% 824

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oppenheimer Asset Management's DPLO Position: Q1 2019 in Review

Oppenheimer Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 5,167 shares — an estimated $69K sold.

Oppenheimer Asset Management first reported a position in DPLO in Q1 2017 and held it in 5 quarters. The position peaked at $602K in Q4 2017. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • Oppenheimer Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • Oppenheimer Asset Management sold 5,167 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $69K.
  • Oppenheimer Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 5 quarters.
  • Oppenheimer Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $602K in Q4 2017.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on Oppenheimer Asset Management's 13F filing for Q1 2019, filed 24 Apr 2019.